DE3885461T2 - Biospezifische polymere. - Google Patents

Biospezifische polymere.

Info

Publication number
DE3885461T2
DE3885461T2 DE88907973T DE3885461T DE3885461T2 DE 3885461 T2 DE3885461 T2 DE 3885461T2 DE 88907973 T DE88907973 T DE 88907973T DE 3885461 T DE3885461 T DE 3885461T DE 3885461 T2 DE3885461 T2 DE 3885461T2
Authority
DE
Germany
Prior art keywords
biospecific polymers
biospecific
polymers
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE88907973T
Other languages
English (en)
Other versions
DE3885461D1 (de
Inventor
G Mccain
Robert Jarrett
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kanegafuchi Chemical Industry Co Ltd
Original Assignee
Kanegafuchi Chemical Industry Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kanegafuchi Chemical Industry Co Ltd filed Critical Kanegafuchi Chemical Industry Co Ltd
Application granted granted Critical
Publication of DE3885461D1 publication Critical patent/DE3885461D1/de
Publication of DE3885461T2 publication Critical patent/DE3885461T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A61K35/16—Blood plasma; Blood serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/30—Nerves; Brain; Eyes; Corneal cells; Cerebrospinal fluid; Neuronal stem cells; Neuronal precursor cells; Glial cells; Oligodendrocytes; Schwann cells; Astroglia; Astrocytes; Choroid plexus; Spinal cord tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/58—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/68—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
    • A61K47/6835—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site
    • A61K47/6883—Polymer-drug antibody conjugates, e.g. mitomycin-dextran-Ab; DNA-polylysine-antibody complex or conjugate used for therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/36—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
    • A61M1/3679—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits by absorption
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/36—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
    • A61M1/3687—Chemical treatment
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/02—Antidotes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/16—Extraction; Separation; Purification by chromatography
    • C07K1/22—Affinity chromatography or related techniques based upon selective absorption processes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/06—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from serum
    • C07K16/065—Purification, fragmentation
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/26—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against hormones ; against hormone releasing or inhibiting factors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/42—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins
    • C07K16/4283—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an allotypic or isotypic determinant on Ig
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K17/00—Carrier-bound or immobilised peptides; Preparation thereof
    • C07K17/02—Peptides being immobilised on, or in, an organic carrier
    • C07K17/08—Peptides being immobilised on, or in, an organic carrier the carrier being a synthetic polymer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
DE88907973T 1987-08-14 1988-08-11 Biospezifische polymere. Expired - Fee Related DE3885461T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/086,307 US4737544A (en) 1982-08-12 1987-08-14 Biospecific polymers

Publications (2)

Publication Number Publication Date
DE3885461D1 DE3885461D1 (de) 1993-12-09
DE3885461T2 true DE3885461T2 (de) 1994-02-24

Family

ID=22197703

Family Applications (1)

Application Number Title Priority Date Filing Date
DE88907973T Expired - Fee Related DE3885461T2 (de) 1987-08-14 1988-08-11 Biospezifische polymere.

Country Status (8)

Country Link
US (1) US4737544A (de)
EP (1) EP0374182B1 (de)
JP (1) JPH0684312B2 (de)
AU (1) AU616618B2 (de)
DE (1) DE3885461T2 (de)
IL (1) IL87237A0 (de)
PL (1) PL274213A1 (de)
WO (1) WO1989001335A1 (de)

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4966791A (en) * 1986-03-11 1990-10-30 Union Oil Company Of California Methods for manufacturing textile materials
DE3778446D1 (de) * 1986-08-18 1992-05-27 Mueller Lierheim Wolfgang G K Kontaktlinse.
JPH03505287A (ja) * 1988-06-20 1991-11-21 イー・アイ・デユポン・ドウ・ヌムール・アンド・カンパニー 生理学的流体を処理するための生物適合性、物質特異的試薬
US5252459A (en) * 1988-09-23 1993-10-12 Abbott Laboratories Indicator reagents, diagnostic assays and test kits employing organic polymer latex particles
US5078673A (en) * 1988-11-14 1992-01-07 Neorx Corporation Selective removal of radiolabeled antibodies
US5565519A (en) * 1988-11-21 1996-10-15 Collagen Corporation Clear, chemically modified collagen-synthetic polymer conjugates for ophthalmic applications
US5162430A (en) * 1988-11-21 1992-11-10 Collagen Corporation Collagen-polymer conjugates
US5510418A (en) * 1988-11-21 1996-04-23 Collagen Corporation Glycosaminoglycan-synthetic polymer conjugates
US5306500A (en) * 1988-11-21 1994-04-26 Collagen Corporation Method of augmenting tissue with collagen-polymer conjugates
CA2026881A1 (en) * 1989-02-08 1990-08-09 Masao Tanihara Peptide and adsorbent thereof immobilized on carrier
US5807747A (en) * 1989-06-13 1998-09-15 Clinical Innovations Limited Method and apparatus for determination of glycosylated protein
DE3923342A1 (de) * 1989-07-14 1991-01-24 Boehringer Mannheim Gmbh Verfahren zur herstellung mit einer immunologisch aktiven substanz beschichteten festphasenmatrix
US5071909A (en) * 1989-07-26 1991-12-10 Millipore Corporation Immobilization of proteins and peptides on insoluble supports
AT397723B (de) * 1989-08-21 1994-06-27 Epipharm Allergie Service Verfahren zur herstellung radiokonjugierter polymerer und verwendung derselben
US5369204A (en) * 1991-11-01 1994-11-29 Cytec Technology Corp. Low molecular weight acrylamidoglycolate crosslinker and process
AU6915894A (en) * 1993-05-17 1994-12-12 Massachusetts Institute Of Technology Artificial receptors, antibodies, and enzymes
FR2707010B1 (de) * 1993-06-25 1995-09-29 Bio Merieux
US5753227A (en) 1993-07-23 1998-05-19 Strahilevitz; Meir Extracorporeal affinity adsorption methods for the treatment of atherosclerosis, cancer, degenerative and autoimmune diseases
PT820483E (pt) * 1995-04-07 2001-03-30 Mogens Havsteen Jakobsen Metodo de imobilizacao fotoquimica de ligandos usando quinonas
US5554365A (en) * 1995-05-05 1996-09-10 Medlogic Global Corporation Use of cyanoacrylate adhesive compositions to inhibit acute radiation-induced skin damage
US5804318A (en) * 1995-10-26 1998-09-08 Corvita Corporation Lubricious hydrogel surface modification
US7883693B2 (en) 1995-12-18 2011-02-08 Angiodevice International Gmbh Compositions and systems for forming crosslinked biomaterials and methods of preparation of use
PT876165E (pt) * 1995-12-18 2006-10-31 Angiotech Biomaterials Corp Composicoes de polimeros reticulados e processos para a sua utilizacao
US6833408B2 (en) * 1995-12-18 2004-12-21 Cohesion Technologies, Inc. Methods for tissue repair using adhesive materials
US6458889B1 (en) 1995-12-18 2002-10-01 Cohesion Technologies, Inc. Compositions and systems for forming crosslinked biomaterials and associated methods of preparation and use
US6197289B1 (en) 1997-07-01 2001-03-06 Terumo Cardiovascular Systems Corporation Removal of biologically active agents
US6146771A (en) * 1997-07-01 2000-11-14 Terumo Cardiovascular Systems Corporation Process for modifying surfaces using the reaction product of a water-insoluble polymer and a polyalkylene imine
WO1999033419A1 (en) * 1997-12-31 1999-07-08 Depuy Orthopaedics, Inc. Tissue reactive adhesive compositions
US6531591B1 (en) 1999-07-07 2003-03-11 Exiqon A/S Synthesis of stable quinone and photoreactive ketone phosphoramidite reagents for solid phase synthesis of photoreactive-oligomer conjugates
US6444254B1 (en) * 2000-03-03 2002-09-03 Duke University Microstamping activated polymer surfaces
US7163712B2 (en) * 2000-03-03 2007-01-16 Duke University Microstamping activated polymer surfaces
DE10116042A1 (de) * 2001-03-30 2002-10-24 Fresenius Hemocare Gmbh Exotoxin-Ligand
EP1575507A2 (de) * 2002-04-02 2005-09-21 Scantibodies Laboratory, Inc. Verfahren und vorrichtungen zur behandlung von schweren peripheren bakteriellen infektionen
WO2004060405A2 (en) * 2002-12-30 2004-07-22 Angiotech International Ag Tissue reactive compounds and compositions and uses thereof
ATE457716T1 (de) 2002-12-30 2010-03-15 Angiotech Int Ag Wirkstofffreisetzung von schnell gelierender polymerzusammensetzung
US7276283B2 (en) * 2004-03-24 2007-10-02 Wisconsin Alumni Research Foundation Plasma-enhanced functionalization of carbon-containing substrates
NZ550964A (en) 2004-04-28 2011-05-27 Angiodevice Internat Gmbh Compositions and systems for forming crosslinked biomaterials and associated methods of preparation and use
WO2006034128A2 (en) 2004-09-17 2006-03-30 Angiotech Biomaterials Corporation Multifunctional compounds for forming crosslinked biomaterials and methods of preparation and use
WO2007008904A2 (en) * 2005-07-08 2007-01-18 The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Targeting poly-gamma-glutamic acid to treat staphylococcus epidermidis and related infections
US8029902B2 (en) * 2006-12-11 2011-10-04 Wisconsin Alumni Research Foundation Plasma-enhanced functionalization of substrate surfaces with quaternary ammonium and quaternary phosphonium groups
AU2008286759B2 (en) 2007-08-15 2014-05-08 Isp Investments Inc. Polyvinylamide polymers containing polymerizable functionalities
US8242224B2 (en) * 2007-08-15 2012-08-14 Isp Investments Inc. Polyvinylamide polymers containing polymerizable functionalities
US9733242B2 (en) 2012-10-07 2017-08-15 Sevident, Inc. Devices for capturing analyte
US9910040B2 (en) 2012-07-09 2018-03-06 Sevident, Inc. Molecular nets comprising capture agents and linking agents
US20110295175A1 (en) * 2010-03-16 2011-12-01 Marv Enterprises Llc Sequential Extracoporeal Treatment of Bodily Fluids

Family Cites Families (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US31712A (en) * 1861-03-19 Improvement in plows
US4061141A (en) * 1969-03-21 1977-12-06 Viktor Holger Hyden Apparatus and method for selectively separating amino acids and defined proteins in blood
US3787380A (en) * 1971-10-05 1974-01-22 Union Optics Corp Polymers of n-vinyl or n-allyl hetero-cyclic compounds with monoethyl-enically unsaturated esters and gly-cidyl esters
CS167530B1 (en) * 1972-03-29 1976-04-29 Jiri Coupek Method of insoluble biologically active compounds preparation
US3826678A (en) * 1972-06-06 1974-07-30 Atomic Energy Commission Method for preparation of biocompatible and biofunctional materials and product thereof
US3896217A (en) * 1973-03-19 1975-07-22 Summa Corp Method and apparatus for radioimmunoassay with regeneration of immunoadsorbent
US4192748A (en) * 1973-07-05 1980-03-11 Hyden Viktor H Dialysis apparatus with selective chemical activity
US4070348A (en) * 1973-07-25 1978-01-24 Rohm Gmbh Water-swellable, bead copolymer
US4182750A (en) * 1977-04-21 1980-01-08 Sullivan Thomas E Bloodcompatible functional polymers
ES471585A1 (es) * 1977-07-15 1979-01-16 Behringwerke Ag Procedimiento para la determinacion de reactivos fc
CA1104110A (en) * 1978-04-27 1981-06-30 Sumitomo Chemical Company, Limited Enzyme-immobilization carriers and preparation thereof
IT1156741B (it) * 1978-05-15 1987-02-04 Sigma Tau Ind Farmaceuti Applicazione terapeutica della carnitina e di alcuni derivati acilati della carnitina nell'emodialisi
US4292296A (en) * 1978-09-12 1981-09-29 Baxter Travenol Laboratories, Inc. Diagnostic method
US4222907A (en) * 1978-09-25 1980-09-16 Scripps Clinic & Research Foundation Induction of immunological tolerance
US4182250A (en) * 1979-02-02 1980-01-08 The Singer Company Bobbin thread control means for a lock stitch sewing machine
US4656308A (en) * 1979-05-29 1987-04-07 American Cyanamid Company Ethers of acrylamidoglycolic acid and esters
US4305926A (en) * 1979-09-13 1981-12-15 Johannes Everse Immobilization of Streptokinase
JPS5670028A (en) * 1979-11-12 1981-06-11 Teijin Ltd Polymer bonding with albumin
USRE31712E (en) 1980-01-24 1984-10-23 Biochemical avidin-biotin multiple-layer system
JPS56115727A (en) * 1980-02-19 1981-09-11 Kuraray Co Ltd Carrier for immobilizing physiologically active substance
US4357311A (en) * 1980-10-03 1982-11-02 Warner-Lambert Company Substrate for immunoassay and means of preparing same
JPS5796261A (en) * 1980-12-09 1982-06-15 Toray Ind Inc Preparation of immunoactive particle
EP0054249B2 (de) * 1980-12-09 1993-04-21 Toray Industries, Inc. Immunologische Teilchen und Verfahren zur Herstellung derselben
JPS5796260A (en) * 1980-12-09 1982-06-15 Toray Ind Inc Immunoactive particle
JPS57103649A (en) * 1980-12-18 1982-06-28 Asahi Chemical Ind Sterilized gamma-globulin fixing column
US4381004A (en) * 1981-01-15 1983-04-26 Biomedics, Inc. Extracorporeal system for treatment of infectious and parasitic diseases
GB2092470B (en) * 1981-02-10 1984-07-18 Tanabe Seiyaku Co Method for reducing the pyrogen content of or removing pyrogens from solutions contaminated therewith
DE3109123A1 (de) * 1981-03-11 1982-09-23 Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V., 8000 München Verfahren zur kovalenten immobilisierung von biologischen detoxikationssystemen auf kuenstlichen oberflaechen
US4362155A (en) * 1981-03-24 1982-12-07 Skurkovich Simon V Method and apparatus for the treatment of autoimmune and allergic diseases
JPS57175128A (en) * 1981-04-22 1982-10-28 Toray Ind Inc Fine particle joined to complement
US4430229A (en) * 1981-05-22 1984-02-07 Asahi Kasei Kogyo Kabushiki Kaisha Immune adsorbent and adsorbing device
JPS5899966A (ja) * 1981-11-30 1983-06-14 コ−ディス、コ−ポレイション 治療的免疫除去装置および方法
EP0103184B1 (de) * 1982-08-12 1990-01-17 Kanegafuchi Chemical Industry Co., Ltd. Aktivierung bioverträglicher Terpolymere mit biologischen Stoffen, deren anzubindende Komplemente pathologische Effektoren sind
SE8204811L (sv) * 1982-08-23 1984-02-24 Sven Lofdahl Dna-fragment innefattande en signalsekvens
US5151350A (en) * 1982-10-27 1992-09-29 Repligen Corporation Cloned genes encoding recombinant protein a
US4614513A (en) * 1984-08-13 1986-09-30 Fred Hutchinson Cancer Research Center Method and apparatus for treatment to remove immunoreactive substances from blood

Also Published As

Publication number Publication date
JPH0684312B2 (ja) 1994-10-26
AU616618B2 (en) 1991-10-31
PL274213A1 (en) 1989-05-02
EP0374182B1 (de) 1993-11-03
WO1989001335A1 (en) 1989-02-23
EP0374182A4 (en) 1991-07-17
DE3885461D1 (de) 1993-12-09
JPH02504635A (ja) 1990-12-27
US4737544A (en) 1988-04-12
IL87237A0 (en) 1988-12-30
AU2386688A (en) 1989-03-09
EP0374182A1 (de) 1990-06-27

Similar Documents

Publication Publication Date Title
DE3885461T2 (de) Biospezifische polymere.
DE59001817D1 (de) Strahlungsempfindliche polymere.
FI883950A0 (fi) Copolymer.
DE68909999T2 (de) Modifizierte Kautschuk-Dienpolymere.
DE3877968T2 (de) Hochamorphes olefinterpolymer.
FI880945A0 (fi) Perforerad, ljudabsorberande skiva.
DE3787312D1 (de) Metallisierte Polymere.
DE3869631D1 (de) Wasseradsorbierende polymere.
DE3884532T2 (de) Polycarbonat-Polyisobutylen - Blockcopolymere.
NO883630D0 (no) Vannherdende polymertilberedning.
FI883112A (fi) Extruder foer polymermaterial.
DE3779091D1 (de) Polyalkoholpolymer.
FI891399A (fi) Polymerer av laegre alkener.
FI894851A0 (fi) Genoeverfoering foer laekemedelsresistens.
FI882642A (fi) Bestrukna syntetiska polymerpelletter.
FI880683A0 (fi) Skodon, isynnerhet sandaler.
DE3868664D1 (de) Aethylencopolymer.
DE58907405D1 (de) Pfropfpolymerisate.
NO852791L (no) Polymere antigroingsmidler.
FI880989A (fi) Skaop, saerskilt badrumsskaop.
DE3689065D1 (de) Komplexbildende Polymere.
DE3875267T2 (de) Heptaenantibiotikum, v-28-3m.
FI872949A0 (fi) Underlagsmatta foer golvbelaeggning, saerskilt foer mosaikparkett.
ATE96672T1 (de) Biospezifische polymere.
NO891651D0 (no) Polymere materialer.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee